Chemoinformaics analysis of 2,6-Dimethylheptane
| Molecular Weight | 128.259 | nRot | 4 |
| Heavy Atom Molecular Weight | 108.099 | nRig | 0 |
| Exact Molecular Weight | 128.156 | nRing | 0 |
| Solubility: LogS | -4.915 | nHRing | 0 |
| Solubility: LogP | 4.835 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 28.3659 |
| nHD | 0 | BPOL | 20.0641 |
| QED | 0.544 |
| Synth | 1.724 |
| Natural Product Likeliness | 0.469 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.004 |
| HIA | 0.004 |
| CACO-2 | -4.2 |
| MDCK | 0.0000208 |
| BBB | 0.867 |
| PPB | 0.958922 |
| VDSS | 1.884 |
| FU | 0.0370171 |
| CYP1A2-inh | 0.846 |
| CYP1A2-sub | 0.509 |
| CYP2c19-inh | 0.444 |
| CYP2c19-sub | 0.871 |
| CYP2c9-inh | 0.719 |
| CYP2c9-sub | 0.941 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.069 |
| CYP3a4-inh | 0.042 |
| CYP3a4-sub | 0.196 |
| CL | 8.58 |
| T12 | 0.271 |
| hERG | 0.017 |
| Ames | 0.006 |
| ROA | 0.061 |
| SkinSen | 0.381 |
| Carcinogencity | 0.085 |
| EI | 0.99 |
| Respiratory | 0.179 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.933314 |